Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Bullboard Post History

by floatinketucky


V.TLT

Me thinks me thinks..

A can of whoop@ss is about to be opened up on this 10 year range... JMO...

January 17, 2022

V.TLT

RE:RE:When is the next 1/4 due out?

No one has crystal ball but last year it was released on the 1st of Febuary.

January 17, 2022

V.TLT

RE:RE:RE:When is the next 1/4 due out?

floatinketucky wrote: When was it released last year? Theralase...

January 17, 2022

V.TLT

RE:RE:When is the next 1/4 due out?

When was it released last year?

January 17, 2022

V.TLT

RE:RE:RE:TLTFF- In good standing to challenge Merck’s Keytruda.

As of November 29, 2021, Study II has enrolled and provided the primary...

January 17, 2022

V.TLT

RE:RE:TLTFF- In good standing to challenge Merck’s Keytruda.

Sept 1 2021 Research Capital RE: Theralase 2021https://www.cantechletter.com...

January 17, 2022

V.TLT

What you gonna do when they stop selling cheap?

Tic toc tic toc.

January 17, 2022

V.TLT

$TLTFF PH 2 PIVITOL TOPPLING DATA

BULLISH BTD

January 17, 2022

V.TLT

RE:RE:RE:RE:RE:Dr. Vera's Move

floatinketucky wrote: The Phase 1-Two single-treated full dose patients were...

January 17, 2022

V.TLT

Additional Theralase cancer research

Theralase Lead Anti-Cancer Drug Effective in the Destruction of Throat Cancer...

January 17, 2022

V.TLT

Theralase launches Anti-Cancer Therapy Research Centre

March 29, 2021, Theralase® Technologies Inc. (“Theralase” or the...

January 17, 2022

V.TLT

RE:TLTFF- In good standing to challenge Merck’s Keytruda.

On the Phase 2 study, Uddin said, “TLT reported an interim analysis across a...

January 17, 2022

V.TLT

RE:RE:RE:BTD

floatinketucky wrote: Study II Status: Theralase® has enrolled and...

January 17, 2022

V.TLT

RE:Dec 2nd 65.2 percent short volume

floatinketucky wrote: open .2066 close .2592 High  .2715 short volume...

January 17, 2022

V.TLT

RE:RE:RE:10 year montly chart. Theralase preparing for range breakout

floatinketucky wrote: floatinketucky wrote: floatinketucky...

January 17, 2022

V.TLT

Regulars on the board and new eyes on the board.

Expect to see more posting from me. While the regulars on the board know the...

January 17, 2022

V.TLT

$TLTFF Consistent insider buying continues. They know.

Insider Filings Latest 10 SEDI filings for TLT within the last 6 months ...

January 17, 2022

V.TLT

RE:made the TOP TEN BULLBOARDS Again

floatinketucky wrote:Mr. Jim Crammer sir, If you note when this board post...

January 13, 2022

V.TLT

RE:RE:RE:Please stop posting old articles about TLT...

https://theralase.com/quarterly-newsletters/quarterly-newsletters

January 13, 2022

V.TLT

RE:RE:Please stop posting old articles about TLT...

Please note Theralase has quartlery newsletters. They are not makeing pot...

January 13, 2022

Featured Company